Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53wt advanced or recurrent endometrial cancer: Follow-up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53wt advanced or recurrent endometrial cancer: Follow-up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study Haluska, P., Perez-Fidalgo, J., Vergote, I., Hamilton, E., de Giorgi, U., Van Gorp, T., Luebbe, K., Zikan, M., Helpman, L., Miller, D. S., Farinas-Madrid, L., Pisano, C., Barbeaux, A., Sehouli, J., Chon, H., Ancizar, N., Berek, J., Kalyanapu, P., Mirza, M., Makker, V. WILEY. 2024: 133-134View details for Web of Science ID 001352150600178